“Lp(a) raises heart disease risk even if your regular cholesterol looks normal.”
High Lp(a), an inherited cholesterol-carrying particle, raises heart disease risk even when standard LDL cholesterol is normal.
High Lp(a) can add inherited heart risk even when your standard cholesterol looks fine. Knowing your level helps you and your clinician manage the risks you can change.
Ask to add an Lp(a) test to your next blood draw if you have never had one.
Safety note: A high result needs interpretation alongside your overall heart risk. In September 2026, Novartis reported that pelacarsen lowered Lp(a) but missed its primary cardiovascular endpoint. This does not establish benefit from taking a drug simply to lower the number.
Talk to a healthcare professional if: heart disease came early or without a clear cause in your family, or you have never had Lp(a) measured. If yours is high, your parents, siblings and children may want testing too.
Strong confidence because large observational and genetic studies consistently show added heart risk from high Lp(a), including when LDL cholesterol is low. Predicting risk and benefiting from a drug that lowers Lp(a) are different questions.
High Lp(a), an inherited cholesterol-carrying particle, raises heart disease risk even when standard LDL cholesterol is normal. A regular cholesterol panel does not measure it.
Lowering Lp(a) with a drug has not yet been shown to prevent heart events: in September 2026, Novartis reported that pelacarsen lowered Lp(a) but missed its main heart-outcome goal. A high result is used as one part of overall heart risk.
- Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. European Heart Journal. 2022;43:3925-3946. DOI: 10.1093/eurheartj/ehac361
- American Heart Association. 2026 Guideline on the Management of Dyslipidemia. Professional Heart Daily. 2026
- Novartis. Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD). Sponsor announcement. 2026-09-04